Paroxysmal Nocturnal Hemoglobinuria (PNH) market size is expected to reach $7.42 billion by 2030 at 9.9%, driven by rising blood and bone marrow disorders.
Read More
Global Parkinson’s Disease market size is expected to reach $5.32 billion by 2030 at 8%, impact of increasing neurodegenerative diseases on the growth of the market
Read More
Urothelial cancer drugs market to reach $8.21 billion by 2030 at 19.4% CAGR, driven by rising prevalence of urothelial cancer and increasing demand for chemotherapy.
Read More
Urology supplements market to reach $2.89 billion by 2030 at 8.0% CAGR, driven by increasing prevalence of urinary tract infections.
Read More
Optical Genome Mapping market size is expected to reach $0.74 billion by 2030 at 25.9%, segmented as by instruments, optical genome mapping systems, imaging systems, detection and analysis devices
Read More
Urokinase market to reach $2.38 billion by 2030 at 5.6% CAGR, driven by growing burden of cardiovascular diseases worldwide.
Read More
Global Optic Neuropathy Management market size is expected to reach $5.07 billion by 2030 at 5.7%, growing prevalence of eye disease fuels the market
Read More
Urinary retention drug market to reach $5.39 billion by 2030 at 5.7% CAGR, driven by rising prevalence of urinary disorders among aging populations.
Read More
Optic Nerve Disorders Treatment market size is expected to reach $5.21 billion by 2030 at 5.7%, segmented as by steroidal therapy, corticosteroids, intravitreal steroid injections, oral steroids
Read More
Urinary ph modifier market to reach $4.11 billion by 2030 at 5.4% CAGR, driven by increasing prevalence of renal failure and preventive healthcare awareness.
Read More